Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Agenus Inc
About AGEN
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer with a comprehensive pipeline of immunological agents. The company is focused on expanding patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants. Its I-O portfolio is driven by several platforms and programs, which include multiple antibody discovery platforms, antibody candidate programs, its saponin-based vaccine adjuvant platform, and a pipeline of novel allogeneic invariant natural killer T cell (iNKT) therapies for treating cancer and other immune-mediated diseases, controlled by MiNK. Its antibody candidate programs include botensilimab (BOT) and balstilimab (BAL) (a PD-1 blocking antibody). The Company has secured committed manufacturing capacity to support BOT+BAL supply needs for its clinical trials, global access programs and future commercialization.
Find out what a historical investment in Agenus Inc would be worth today using our AGEN stock calculator.
Market Capitalisation
$128.68M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
471.46K
High today
$3.25
Low today
$3.12
Open price
$3.12
52-week high
$7.34
52-week low
$2.71
Ready to start your investing journey with Stake?
Open an accountHow do I buy AGEN shares in Australia?
Buying AGEN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Agenus Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AGEN
What is the ticker symbol of Agenus Inc?
The ticker symbol for Agenus Inc is AGEN.
How much is one share of AGEN?
One share of AGEN is valued at $3.15 as of 20 May 2026.
What is the market capitalisation of Agenus Inc AGEN?
As of 20 May 2026 Agenus Inc has a market cap of $128.68M.
What is the P/E ratio of AGEN?
The Price to Earnings ratio of AGEN is 1.86.
What is the Earnings Per Share of AGEN?
The Earnings Per Share of AGEN is $1.66.
What is the 52-week high for Agenus Inc stock?
The Agenus Inc 52-week high stock price is $7.34.
What is the 52-week low for Agenus Inc stock?
The Agenus Inc 52-week low stock price is $2.71.
Can I buy AGEN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AGEN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AGEN on Stake
- Buy AGEN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AGEN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AGEN related stocks